A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers
- PMID: 30714689
- PMCID: PMC6434214
- DOI: 10.1002/cam4.2005
A system-based intervention to reduce Black-White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers
Abstract
Background: Advances in early diagnosis and curative treatment have reduced high mortality rates associated with non-small cell lung cancer. However, racial disparity in survival persists partly because Black patients receive less curative treatment than White patients.
Methods: We performed a 5-year pragmatic, trial at five cancer centers using a system-based intervention. Patients diagnosed with early stage lung cancer, aged 18-85 were eligible. Intervention components included: (1) a real-time warning system derived from electronic health records, (2) race-specific feedback to clinical teams on treatment completion rates, and (3) a nurse navigator. Consented patients were compared to retrospective and concurrent controls. The primary outcome was receipt of curative treatment.
Results: There were 2841 early stage lung cancer patients (16% Black) in the retrospective group and 360 (32% Black) in the intervention group. For the retrospective baseline, crude treatment rates were 78% for White patients vs 69% for Black patients (P < 0.001); difference by race was confirmed by a model adjusted for age, treatment site, cancer stage, gender, comorbid illness, and income-odds ratio (OR) 0.66 for Black patients (95% CI 0.51-0.85, P = 0.001). Within the intervention cohort, the crude rate was 96.5% for Black vs 95% for White patients (P = 0.56). Odds ratio for the adjusted analysis was 2.1 (95% CI 0.41-10.4, P = 0.39) for Black vs White patients. Between group analyses confirmed treatment parity for the intervention.
Conclusion: A system-based intervention tested in five cancer centers reduced racial gaps and improved care for all.
Trial registration: ClinicalTrials.gov NCT01954641 NCT01687738.
Keywords: cancer disparities; health equity; intervention; pragmatic trial; systems change.
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
Cykert has no actual or potential conflicts of interest to report; Eng has no actual or potential conflicts of interest to report; Walker has no actual or potential conflicts of interest to report; Manning has no actual or potential conflicts of interest to report; Robertson has no actual or potential conflicts of interest to report; Arya has no actual or potential conflicts of interest to report; Jones has no actual or potential conflicts of interest to report; Heron has no actual or potential conflicts of interest to report.
Figures
References
-
- Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early‐stage lung cancer. New Engl J Med. 1999;341:1198‐1205. - PubMed
-
- Network NCC . Guidelines version 3.2018 updates non‐small cell lung cancer. 2018. https://www.nccn.org. Accessed May 30, 2018.
-
- Cykert S, Walker PR, Edwards LJ, McGuire FR, Dilworth‐Anderson P. Weighing projections of physical decline in lung cancer surgery decisions. Am J Med Sci. 2015;349:61‐66. - PubMed
-
- Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non‐small‐cell lung cancer. J Clin Oncol. 2006;24:413‐418. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
